VIRIP

Description: VIRIP (human alpha1-AT(353-372)) serves as an inhibitor of HIV-1. It impedes HIV-1 entry by binding to the gp41 fusion peptide, making it useful in virus research. Target: HIV Protease. Smiles: C(=O)([C@H]1N(C([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@H]2N(C([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC(C)C)N)=O)CCC(O)=O)=O)C)=O)[C@H](CC)C)=O)CCC2)CCSC)=O)CO)=O)[C@H](CC)C)=O)CCC1)N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC4=CC=CC=C4)C(N[C@H](C(N[C@H](C(=O)N5[C@H](C(N[C@@H](CC6=CC=CC=C6)C(N[C@H](C(N[C@@H](CC7=CC=CC=C7)C(O)=O)=O)[C@H](C)C)=O)=O)CCC5)CCCCN)=O)CC(N)=O)=O)=O)CCCCN)=O)[C@H](C)C)=O)CCC(O)=O)=O)CCC3